116 related articles for article (PubMed ID: 38552056)
21. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
22. FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1.
Berfelde J; Hildebrand LS; Kuhlmann L; Fietkau R; Distel LV
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396787
[TBL] [Abstract][Full Text] [Related]
23. Transient receptor potential channels as predictive marker and potential indicator of chemoresistance in colon cancer.
Hu W; Wartmann T; Strecker M; Perrakis A; Croner R; Szallasi A; Shi W; Kahlert UD
Oncol Res; 2023; 32(1):227-239. PubMed ID: 38188686
[TBL] [Abstract][Full Text] [Related]
24. Integrated analysis of gene expression signatures associated with colon cancer from three datasets.
Gao P; He M; Zhang C; Geng C
Gene; 2018 May; 654():95-102. PubMed ID: 29408621
[TBL] [Abstract][Full Text] [Related]
25. Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
Liang Y; Zhang C; Dai DQ
World J Gastroenterol; 2019 Jul; 25(26):3392-3407. PubMed ID: 31341364
[TBL] [Abstract][Full Text] [Related]
26. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
27. Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
He L; Zhang Y; Sun H; Jiang F; Yang H; Wu H; Zhou T; Hu S; Kathera CS; Wang X; Chen H; Li H; Shen B; Zhu Y; Guo Z
EBioMedicine; 2016 Dec; 14():32-43. PubMed ID: 27852524
[TBL] [Abstract][Full Text] [Related]
28. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
29. Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy.
Yang F; Hu Z; Guo Z
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883563
[TBL] [Abstract][Full Text] [Related]
30. Transcription factor expression as a predictor of colon cancer prognosis: a machine learning practice.
Liu J; Dong C; Jiang G; Lu X; Liu Y; Wu H
BMC Med Genomics; 2020 Sep; 13(Suppl 9):135. PubMed ID: 32957968
[TBL] [Abstract][Full Text] [Related]
31. Letrozole improves the sensitivity of breast cancer cells overexpressing aromatase to cisplatin via down-regulation of FEN1.
Wang Y; Li S; Zhu L; Zou J; Jiang X; Chen M; Chen B
Clin Transl Oncol; 2019 Aug; 21(8):1026-1033. PubMed ID: 30712236
[TBL] [Abstract][Full Text] [Related]
32. FEN1 mediates miR-200a methylation and promotes breast cancer cell growth
Zeng X; Qu X; Zhao C; Xu L; Hou K; Liu Y; Zhang N; Feng J; Shi S; Zhang L; Xiao J; Guo Z; Teng Y; Che X
FASEB J; 2019 Oct; 33(10):10717-10730. PubMed ID: 31266372
[TBL] [Abstract][Full Text] [Related]
33. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
Ren Y; Lv Y; Li T; Jiang Q
Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
[TBL] [Abstract][Full Text] [Related]
34. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
[No Abstract] [Full Text] [Related]
35. FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
He L; Luo L; Zhu H; Yang H; Zhang Y; Wu H; Sun H; Jiang F; Kathera CS; Liu L; Zhuang Z; Chen H; Pan F; Hu Z; Zhang J; Guo Z
Mol Oncol; 2017 Jun; 11(6):640-654. PubMed ID: 28371273
[TBL] [Abstract][Full Text] [Related]
36. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X; Cheng Z; Chen X; Li J
Front Genet; 2022; 13():955424. PubMed ID: 36046241
[No Abstract] [Full Text] [Related]
37. Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer.
Wang D; Zhang Y; Wang X; Zhang L; Xu S
Front Genet; 2023; 14():1022265. PubMed ID: 36741321
[No Abstract] [Full Text] [Related]
38. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data.
Chai R; Zhao Y; Su Z; Liang W
Front Oncol; 2023; 13():1277084. PubMed ID: 38023180
[TBL] [Abstract][Full Text] [Related]
39. Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes.
Ward TA; McHugh PJ; Durant ST
PLoS One; 2017; 12(6):e0179278. PubMed ID: 28628639
[TBL] [Abstract][Full Text] [Related]
40. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
